PortfoliosLab logoPortfoliosLab logo
AMPH vs. TRT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AMPH vs. TRT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amphastar Pharmaceuticals, Inc. (AMPH) and Trio-Tech International (TRT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AMPH achieves a -25.54% return, which is significantly lower than TRT's 50.76% return. Over the past 10 years, AMPH has underperformed TRT with an annualized return of 2.12%, while TRT has yielded a comparatively higher 19.08% annualized return.


AMPH

1D
-2.16%
1M
1.53%
6M
-24.73%
YTD
-25.54%
1Y
-5.99%
3Y*
-30.98%
5Y*
-0.98%
10Y*
2.12%
ALL TIME*
9.04%

TRT

1D
1.11%
1M
-3.85%
6M
77.26%
YTD
50.76%
1Y
264.90%
3Y*
51.59%
5Y*
32.65%
10Y*
19.08%
ALL TIME*
7.24%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$8.38M$7.78M$11.79M
$3.65M$4.73M$11.73M

AMPH vs. TRT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AMPH
Amphastar Pharmaceuticals, Inc.
-25.54%-27.88%-39.97%120.74%20.31%15.81%4.25%-3.07%3.43%4.45%
TRT
Trio-Tech International
50.76%127.88%14.60%12.66%-66.49%239.01%-0.71%62.20%-64.91%111.35%

Correlation

The correlation between AMPH and TRT is -0.08, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

-0.08

Correlation (3Y)
Balances recent behavior with more history.

-0.00

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.03

Correlation (10Y)
Provides a long-term view across more market conditions.

0.06

Correlation (All Time)
Calculated using the full available price history since Jun 25, 2014

0.06

The correlation between AMPH and TRT shifts across timeframes, from -0.08 (1 year) to 0.06 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AMPH:

$879.21M

TRT:

$100.92M

EPS

AMPH:

$1.68

TRT:

$0.07

PE Ratio

AMPH:

11.85

TRT:

141.58

PEG Ratio

AMPH:

0.63

TRT:

15.62

PS Ratio

AMPH:

1.30

TRT:

2.16

PB Ratio

AMPH:

1.20

TRT:

2.83

Total Revenue (TTM)

AMPH:

$720.53M

TRT:

$41.83M

Gross Profit (TTM)

AMPH:

$341.13M

TRT:

$10.27M

EBITDA (TTM)

AMPH:

$155.96M

TRT:

$2.03M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AMPH vs. TRT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

AMPH
AMPH Risk / Return Rank: 4141
Overall Rank
AMPH Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
AMPH Sortino Ratio Rank: 4040
Sortino Ratio Rank
AMPH Omega Ratio Rank: 4141
Omega Ratio Rank
AMPH Calmar Ratio Rank: 4141
Calmar Ratio Rank
AMPH Martin Ratio Rank: 4141
Martin Ratio Rank

TRT
TRT Risk / Return Rank: 9393
Overall Rank
TRT Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
TRT Sortino Ratio Rank: 9393
Sortino Ratio Rank
TRT Omega Ratio Rank: 9292
Omega Ratio Rank
TRT Calmar Ratio Rank: 9595
Calmar Ratio Rank
TRT Martin Ratio Rank: 9292
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

AMPH vs. TRT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Trio-Tech International (TRT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AMPHTRTDifference
Sharpe ratioReturn per unit of total volatility

-2.16

Sortino ratioReturn per unit of downside risk

-2.90

Omega ratioGain probability vs. loss probability

1.04

1.40

-0.36

Calmar ratioReturn relative to maximum drawdown

-0.11

4.92

-5.03

Martin ratioReturn relative to average drawdown

-0.19

11.09

-11.28

AMPH vs. TRT - Sharpe Ratio Comparison

The current AMPH Sharpe Ratio is -0.09, which is lower than the TRT Sharpe Ratio of 2.07. The chart below compares the historical Sharpe Ratios of AMPH and TRT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AMPH vs. TRT - Drawdown Comparison

The maximum AMPH drawdown since its inception was -74.05%, smaller than the maximum TRT drawdown of -95.03%. Use the drawdown chart below to compare losses from any high point for AMPH and TRT.


Loading charts...

Drawdown Indicators


AMPHTRTDifference

Max Drawdown

Largest peak-to-trough decline

-74.05%

-95.03%

+20.98%

Max Drawdown (1Y)

Largest decline over 1 year

-45.25%

-54.61%

+9.36%

Max Drawdown (3Y)

Largest decline over 3 years

-74.05%

-54.61%

-19.44%

Max Drawdown (5Y)

Largest decline over 5 years

-74.05%

-69.77%

-4.28%

Max Drawdown (10Y)

Largest decline over 10 years

-74.05%

-70.64%

-3.41%

Current Drawdown

Current decline from peak

-69.32%

-50.22%

-19.10%

Average Drawdown

Average peak-to-trough decline

-24.58%

-67.94%

+43.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.36%

24.19%

+1.17%

Volatility

AMPH vs. TRT - Volatility Comparison

The current volatility for Amphastar Pharmaceuticals, Inc. (AMPH) is 11.76%, while Trio-Tech International (TRT) has a volatility of 28.00%. This indicates that AMPH experiences smaller price fluctuations and is considered to be less risky than TRT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AMPHTRTDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.76%

28.00%

-16.24%

Volatility (6M)

Calculated over the trailing 6-month period

47.41%

110.80%

-63.39%

Volatility (1Y)

Calculated over the trailing 1-year period

55.13%

129.61%

-74.48%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.68%

81.79%

-36.11%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

42.88%

68.79%

-25.91%

Dividends

AMPH vs. TRT - Dividend Comparison

Neither AMPH nor TRT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

AMPH vs. TRT - Financials Comparison

This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Trio-Tech International. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


AMPH and TRT have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TRT has higher volatility (28.00%) compared to AMPH (11.76%). In terms of maximum drawdown, AMPH dropped -74.05% vs TRT's -95.03%.

TRT currently has the higher Sharpe Ratio (2.07 vs -0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AMPH and TRT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer